171 related articles for article (PubMed ID: 11862731)
21. FDA approves first nucleic acid test for HIV and HCV.
Infect Control Hosp Epidemiol; 2001 Dec; 22(12):788-9. PubMed ID: 11876460
[No Abstract] [Full Text] [Related]
22. Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors.
Lee S; Hu J; Tang S; Wood O; Francis K; Machuca A; Rios M; Daniel S; Vockley C; Awazi B; Zekeng L; Hewlett I
J Med Virol; 2006; 78 Suppl 1():S22-3. PubMed ID: 16622873
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Hourfar MK; Schmidt M; Seifried E; Roth WK
Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
[TBL] [Abstract][Full Text] [Related]
24. Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
O'Brien SF; Fan W; Scalia V; Goldman M; Fearon MA; Vamvakas EC
Vox Sang; 2006 Apr; 90(3):204. PubMed ID: 16507022
[No Abstract] [Full Text] [Related]
25. Large scale PCR screening of pooled plasma samples for HIV-1 and HCV.
Smith R; Heldebrant C
Dev Biol (Basel); 2000; 102():109-11. PubMed ID: 10794097
[No Abstract] [Full Text] [Related]
26. [Hepatitis C virus RNA and nucleic acid testing].
Ohishi W; Chayama K
Nihon Rinsho; 2010 Jun; 68 Suppl 6():450-3. PubMed ID: 20942101
[No Abstract] [Full Text] [Related]
27. [New test for determination of HIV-1 RNA level].
Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1680. PubMed ID: 12931729
[No Abstract] [Full Text] [Related]
28. HIV-1 and HCV infections among antibody-negative blood donors.
Laperche S; Pillonel J; Herve P
N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559959
[No Abstract] [Full Text] [Related]
29. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
[TBL] [Abstract][Full Text] [Related]
31. Performance of two triplex nucleic acid test systems.
Fang CT; Lelie N
Transfusion; 2010 Jun; 50(6):1399-400; author reply 1400-1. PubMed ID: 20598102
[No Abstract] [Full Text] [Related]
32. Test to help diagnose HIV-1 infection.
FDA Consum; 2007; 41(1):5. PubMed ID: 17342828
[No Abstract] [Full Text] [Related]
33. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
34. Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Tobler LH; Dockter J; Stramer SL; Kleinman SH; Todd D; Giachetti C; Busch MP
Transfusion; 2002 Nov; 42(11):1525-7. PubMed ID: 12421231
[No Abstract] [Full Text] [Related]
35. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
[No Abstract] [Full Text] [Related]
36. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
37. [The prospect on the technique of test for blood donor infected with hepatitis C virus during the infectious window period].
Zheng H
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):159-60. PubMed ID: 11983147
[No Abstract] [Full Text] [Related]
38. Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.
Schutten M; Fries E; Burghoorn-Maas C; Niesters HG
J Clin Virol; 2007 Oct; 40(2):99-104. PubMed ID: 17768084
[TBL] [Abstract][Full Text] [Related]
39. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
40. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
